期刊文献+

复方血栓通胶囊对弥散性血管内凝血模型大鼠肝肾功能的影响 被引量:5

Effects of Compound Xueshuantong Capsule on the hepatic and renal function of rats with disseminated intravascular coagulation
下载PDF
导出
摘要 采用脂多糖LPS诱导的弥散性血管内凝血DIC模型,探讨复方血栓通胶囊对肝肾等器官的损伤以及血栓沉积的影响。结果表明,复方血栓通胶囊能够显著抑制DIC模型大鼠天冬氨酸氨基转移酶、丙氨酸氨基转移酶、尿素氮、肌酐的升高,显著抑制肝肾组织血栓的形成、出血以及炎性细胞的浸润。本研究为复方血栓通胶囊的临床合理用药提供了依据。 The effects of Compound Xueshuantong Capsule(CXC)on the hepatic and renal function of rats with disseminated intravascular coagulation were assessed.Biochemical tests showed that CXC could significantly decrease the levels of the alanine aminotransferase(ALT)and aspartate aminotransferase(AST)in liver,and the levels of the urea nitrogen(UN)and creatinine(CR)in kidney.Histological observations showed that CXC could significantly inhibit thrombosis,hemorrhage,and inflammation infiltration in both liver and kidney.The results indicated that CXC could significantly improve the liver and kidney function,providing useful references for its clinical medication.
作者 刘宏 生书晶 苏薇薇 LIU Hong;SHENG Shujing;SU Weiwei(School of Life Sciences,Sun Yat-sen University∥Guangdong Engineering and Technology Research Center for Quality and Efficacy Re-Evaluation of Post-Marketed TCM, Guangzhou 510275,China)
出处 《中山大学学报(自然科学版)》 CAS CSCD 北大核心 2018年第6期97-102,共6页 Acta Scientiarum Naturalium Universitatis Sunyatseni
基金 广东省名优中成药二次开发项目(2017-No.19)
关键词 复方血栓通胶囊 弥散性血管内凝血 肝肾功能 Compound Xueshuantong Capsule disseminated intravascular coagulation hepatic and renal function
  • 相关文献

参考文献1

二级参考文献20

  • 1Li PL,Su WW,Xie CS,et al.Rapid identification and simultaneous quantification of multiple constituents in naoshuan-tong capsule by ultra-fast liquid chromatography/diodearray detector/quadrupole time-of-flight tandem mass spectrometry[J].J Chromatogr Sci,2015,53(6):886-897.
  • 2Li PL,Liu MH,Hu JH,et al.Systematic chemical profiling of Citrus grandis‘Tomentosa’by ultra-fast liquid chromatography/diode-array detector/quadrupole time-of-flight tandem mass spectrometry[J].J Pharm Biomed Anal,2014,90:167-179.
  • 3苏薇薇,龙超峰,刘宏,等.中药大品种技术升级的示范研究[M].广州:广东科技出版社,2015.
  • 4苏薇薇,龙超峰,白杨,等.复方血栓通制剂HPLC指纹图谱的构建方法及其标准指纹图谱:中国,ZL200510033778.3[P].2010-04.
  • 5苏薇薇,龙超峰,刘宏,等.一种复方血栓通制剂生物活性色谱指纹图谱的构建方法:中国,ZL 201310003184.2[P].2014-04.
  • 6Liu H,Liang JP,Li PB,et al.Core bioactive components Promoting blood circulation in the traditional Chinese medicine Compound Xueshuantong capsule(CXC)based on the relevance analysis between chemical HPLC fingerprint and in vivo biological effects[J].PLo S ONE,2014,9(11):e112675.
  • 7L i u H B,W a n g L R,L v M L,e t a l.A l z P l a t f o r m:a n Alzheimer’s disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research[J].J Chem Inf Model,2014,54(4):1050-1060.
  • 8Wang LR,Ma C,Wipf P,et al.Target hunter:an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database[J].AAPS J,2013,15(2):395-406.
  • 9Sheng SJ,Wang JX,Wang LR,et al.Network pharmacology analyses of the antithrombotic pharmacological mechanism of Fufang Xueshuantong capsule with experimental support using disseminated intravascular coagulation rats[J].J Ethnopharmacol,2014,54(3):735-744.
  • 10Sheng SJ,Wang YG,Long CF,et al.Chinese medicinalformula Fufang Xueshuantong capsule could inhibit the activity of angiotensin converting enzyme[J].Biotechnol Biotechnol Equip,2014,28(2):322-326.

共引文献2

同被引文献81

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部